z-logo
open-access-imgOpen Access
Threonine 80 phosphorylation of non‐structural protein 1 regulates the replication of influenza A virus by reducing the binding affinity with RIG‐I
Author(s) -
Zheng Weinan,
Cao Shuaishuai,
Chen Can,
Li Jing,
Zhang Shuang,
Jiang Jingwen,
Niu Yange,
Fan Wenhui,
Li Yun,
Bi Yuhai,
Gao George F.,
Sun Lei,
Liu Wenjun
Publication year - 2017
Publication title -
cellular microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.542
H-Index - 138
eISSN - 1462-5822
pISSN - 1462-5814
DOI - 10.1111/cmi.12643
Subject(s) - biology , nucleoprotein , ribonucleoprotein , viral replication , influenza a virus , mutant , phosphorylation , virus , virology , viral matrix protein , transcription (linguistics) , microbiology and biotechnology , gene , biochemistry , rna , linguistics , philosophy
Summary Influenza A virus evades host antiviral defense through hijacking innate immunity by its non‐structural protein 1 (NS1). By using mass spectrometry, threonine 80 (T80) was identified as a novel phosphorylated residue in the NS1 of the influenza virus A/WSN/1933(H1N1). By generating recombinant influenza viruses encoding NS1 T80 mutants, the roles of this phosphorylation site were characterized during viral replication. The T80E (phosphomimetic) mutant attenuated virus replication, whereas the T80A (non‐phosphorylatable) mutant did not. Similar phenotypes were observed for these mutants in a mouse model experiment. In further study, the T80E mutant decreased the binding capacity between NS1 and viral nucleoprotein (NP), leading to impaired viral ribonucleoprotein (vRNP)‐mediated viral transcription. The T80E mutant was also unable to inhibit interferon (IFN) production by reducing the binding affinity between NS1 and retinoic acid‐induced gene 1 protein (RIG‐I), causing attenuation of virus replication. Taken together, the present study reveals that T80 phosphorylation of NS1 reduced influenza virus replication through controlling RIG‐I‐mediated IFN production and vRNP activity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here